Susquehanna Fundamental Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-42,353
Closed -$45.3K 355
2023
Q3
$45.3K Hold
42,353
﹤0.01% 353
2023
Q2
$110K Hold
42,353
﹤0.01% 603
2023
Q1
$173K Sell
42,353
-1,604
-4% -$6.54K ﹤0.01% 880
2022
Q4
$221K Buy
+43,957
New +$221K ﹤0.01% 1055